Jiaojiao Deng

发表

In situ gel-forming AP-57 peptide delivery system for cutaneous wound healing.

Meijia Yang, A. Tong, G. Guo, 2015, International journal of pharmaceutics.

High Tumor Mitochondrial DNA Content Correlates With an Improved Patient's Outcome in WHO Grade III Meningioma

H. Wakimoto, T. Juratli, Y. Gong, 2020, Frontiers in Oncology.

Expression and clinical significance of immune checkpoint regulator B7-H3 (CD276) in human meningioma.

Z. Qian, Hong Chen, Y. Gong, 2020, World neurosurgery.

Long-term outcomes of multimodality management for parasagittal meningiomas

H. Wakimoto, S. Luan, Hailiang Tang, 2020, Journal of Neuro-Oncology.

LncRNA-IMAT1 Promotes Invasion of Meningiomas by Suppressing KLF4/hsa-miR22-3p/Snai1 Pathway

S. Luan, Y. Gong, Jiaojiao Deng, 2022, Molecules and cells.

Molecular diagnosis and treatment of meningiomas: an expert consensus (2022)

Xiaochuan Sun, Ligang Chen, L. Bian, 2022, Chinese medical journal.

Application of MRI-Based Radiomics in Preoperative Prediction of NF2 Alteration in Intracranial Meningiomas

N. Liu, Y. Gong, Jiawei Chen, 2022, Frontiers in Oncology.

Clinical and prognostic features of spinal meningioma: a thorough analysis from a single neurosurgical center

H. Wakimoto, S. Luan, Hailiang Tang, 2018, Journal of Neuro-Oncology.

Progesterone receptor expression and prediction of benefits of adjuvant radiotherapy in de novo atypical meningiomas after gross-total resection.

H. Wakimoto, Y. Gong, Jiawei Chen, 2022, Journal of neurosurgery.

Clinical and prognostic role of annexin A2 in adamantinomatous craniopharyngioma

Yuelong Wang, A. Tong, G. Guo, 2016, Journal of Neuro-Oncology.

Loss of H3K27me3 expression enriches in recurrent grade 1&2 meningiomas and maintains as a biomarker stratifying progression risk

H. Wakimoto, Hong Chen, Y. Gong, 2022, Journal of Neuro-Oncology.

Curcumin exerts its tumor suppressive function via inhibition of NEDD4 oncoprotein in glioma cancer cells

Yuelong Wang, Jin Yuan, Liangxue Zhou, 2017, International journal of oncology.

Prognostic Model That Predicts Benefits of Adjuvant Radiotherapy in Patients With High Grade Meningioma

H. Wakimoto, Y. Gong, Jiaojiao Deng, 2020, Frontiers in Oncology.

The CREB-binding protein inhibitor ICG-001: a promising therapeutic strategy in sporadic meningioma with NF2 mutations

T. Han, L. Wan, Hailiang Tang, 2020, Neuro-oncology advances.

m6A Regulator Expression Segregates Meningiomas Into Biologically Distinct Subtypes

M. Weller, H. Wirsching, Y. Gong, 2021, Frontiers in Oncology.

Targeted Disruption of V600E-Mutant BRAF Gene by CRISPR-Cpf1

Meijia Yang, Yuelong Wang, A. Tong, 2017, Molecular therapy. Nucleic acids.

A Novel Brain-Permeant Chemotherapeutic Agent for the Treatment of Brain Metastasis in Triple-Negative Breast Cancer

Yuelong Wang, G. Ringold, W. Fischer, 2021, Molecular Cancer Therapeutics.

MCT FIRST DISCLOSURES ANovel Brain-Permeant ChemotherapeuticAgent for the Treatment of Brain Metastasis in Triple-Negative Breast Cancer

Yuelong Wang, G. Ringold, W. Fischer, 2021 .

Sparganosis of the brain: a case report and brief review

Wei Guo, Hailiang Tang, Y. Gong, 2017 .

TERT Alterations Predict Tumor Progression in De Novo High-Grade Meningiomas Following Adjuvant Radiotherapy

Y. Gong, Jiawei Chen, Jiaojiao Deng, 2021, Frontiers in Oncology.

The Diagnostic Value Of Using 18F-Fluorodeoxyglucose Positron Emission Tomography To Differentiate Between Low- And High-Grade Meningioma

Y. Guan, Hailiang Tang, Y. Gong, 2019, Cancer management and research.

Characterization of novel CTNNB1 mutation in Craniopharyngioma by whole-genome sequencing

Yong Peng, Yuelong Wang, A. Tong, 2021, Molecular Cancer.

Favorable Long-Term Outcomes of Chordoid Meningioma Compared With the Other WHO Grade 2 Meningioma Subtypes

H. Wakimoto, Y. Gong, Jiawei Chen, 2022, Neurosurgery.

Distinct clinical outcome of microcystic meningioma as a WHO grade 1 meningioma subtype

H. Wakimoto, Zhongyuan Bao, T. Juratli, 2022, Journal of Neuro-Oncology.

Microcystic Meningioma Has A Worse Outcome Than Other WHO Grade 1 Subtypes

H. Wakimoto, Zhongyuan Bao, T. Juratli, 2022 .

Whole-genome sequencing identifies new genetic alterations in meningiomas

Meijia Yang, Yuelong Wang, A. Tong, 2017, Oncotarget.

Expression and clinical significance of PD-L1, B7-H3, B7-H4 and VISTA in craniopharyngioma

Yuelong Wang, A. Tong, Liangxue Zhou, 2020, Journal for ImmunoTherapy of Cancer.

Zonisamide-loaded triblock copolymer nanomicelles as a novel drug delivery system for the treatment of acute spinal cord injury

Yuelong Wang, A. Tong, G. Guo, 2017, International journal of nanomedicine.

Dual Drug Loaded Biodegradable Nanofibrous Microsphere for Improving Anti-Colon Cancer Activity

Xiaoling Li, A. Tong, G. Guo, 2016, Scientific Reports.

Fabrication and in vivo chondrification of a poly(propylene carbonate)/L-lactide-grafted tetracalcium phosphate electrospun scaffold for cartilage tissue engineering

M. Gou, Yuelong Wang, A. Tong, 2015 .

The development of a combined clinico-radiomics model for predicting post-operative recurrence in atypical meningiomas: a multicenter study

Jiawei Chen, Jiaojiao Deng, Lingyang Hua, 2023, Journal of neuro-oncology.

Novel nanoscale topography on poly(propylene carbonate)/poly(ε-caprolactone) electrospun nanofibers modifies osteogenic capacity of ADCs

Yuelong Wang, A. Tong, G. Guo, 2015 .

CBX7 reprograms metabolic flux to protect against meningioma progression by modulating the USP44/c-MYC/LDHA axis

Zeyidan Jiapaer, Hailiang Tang, Zhongyuan Bao, 2023, Journal of molecular cell biology.